Content overview: “Evaluating Medicare’s RAPID Pathway: Advancements for Adults and Pediatric Gaps | Nova Glo”. The Centers for Medicare & Medicaid Services recently introduced the Rapid Assessment and Pathway for Innovation and Development (RAPID) to accelerate the... The Centers for Medicare & Medicaid Services recently introduced the Rapid Assessment and Pathway for Innovation and Development (RAPID) to accelerate the transition of medical devices from clinical trials to reimbursement for adults. This milestone addresses significant regulatory hurdles and is widely considered a major advancement in streamlining modern medical innovation.
However, the introduction of this pathway has highlighted a growing disparity in the healthcare landscape. While adult patient advocacy groups and industry leaders celebrate this progress, the pediatric sector remains conspicuously absent from these improvements. The pediatric medical device industry faces unique regulatory and market challenges that have historically stalled development, leading to a 'valley of death' that the new RAPID pathway has yet to bridge. The full version stays on the original page, which this listing opens directly.